REVB icon

Revelation Biosciences
REVB

Overview Fund Activity

5 hedge funds and large institutions have $3.44M invested in Revelation Biosciences in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 0 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-6
Holders Change %
-54.55%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Axa
1
Axa
France
$2.23M
2
MIM
2
Monashee Investment Management
Massachusetts
$932K
3
Citadel Advisors
3
Citadel Advisors
Florida
$49K
4
BCM
4
Bridgeway Capital Management
Texas
$45K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$37K

Top Sellers

1
KIM
1
Karpus Investment Management
New York
$0
2
WAM
2
Weiss Asset Management
Massachusetts
$0
3
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$0
4
WRBC
4
W.R. Berkley Corp
Connecticut
$0
5
SCM
5
Shaolin Capital Management
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AFM
26
Anson Funds Management
Texas
– -$510K -1 Closed
Marshall Wace
27
Marshall Wace
United Kingdom
– -$508K -1 Closed
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
– -$164K – –
CS
29
Clear Street
New York
– -$157K – –
WFA
30
Wellspring Financial Advisors
Ohio
– -$181K – –
YCM
31
Yakira Capital Management
Connecticut
– -$149K – –
1
2